Skip to content

Azenta AZTA EV / EBITDA

EV / EBITDA at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
21.3×-3.5×
Danaher logo
DanaherDHR
20.5×-2.1×
Labcorp Holdings logo
Labcorp HoldingsLH
13.3×-1.4×
Illumina logo
IlluminaILMN
17.7×
BioLife Solutions logo
BioLife SolutionsBLFS
472.2×
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
195.6×+190×

Other financials

Income statement

See full
Revenue$144.8M+1.0%
Gross profit$62.0M-1.2%
Operating income-$165.8M-811%
Net income-$160.8M-237%
EPS (diluted)-$3.49-236%

Balance sheet

See full
Cash & equivalents$125.2M
Total debt$55.7M
Total equity$1.6B-8.3%
Total assets$1.9B

Cash flow

See full
Operating cash flow$13.5M-6.2%
CapEx$7.4M-0.1%
Free cash flow$6.1M-12.7%

Valuation

See full
Market cap$1.18B-15.4%
Enterprise value$1.11B
P/S-0.3×

Profitability

See full
Gross margin40%-1.0pp
Operating margin-31.6%-59.7pp
Net margin-29.1%-80.7pp
FCF margin8.6%

Returns & leverage

See full
Return on equity-10.7%-22.4pp
Debt / equity
Current ratio2.8×

Where this comes from

Calculated from Azenta’s reported figures.

Based on the most recent quarter.

The official record: Azenta’s 10-Q, filed February 8, 2024, on SEC EDGAR. View the filing →

Ask your AI about Azenta's ev / ebitda.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Azenta's EV / EBITDA?
Azenta (AZTA) reported EV / EBITDA of 201.8× in Q4 2023.
How has Azenta's EV / EBITDA changed year-over-year?
Azenta's EV / EBITDA decreased by 51.1% year-over-year, from 412.8× to 201.8×.
What is the long-term trend for Azenta's EV / EBITDA?
Over 2 years (2021 to 2023), Azenta's EV / EBITDA has grown at a -6.6% compound annual growth rate (CAGR), from 219.3× to 191.4×.
What does EV / EBITDA mean?
Enterprise value (market cap plus total debt minus cash) at the quarter end divided by trailing-twelve-month EBITDA. A capital-structure-neutral valuation multiple.